U.S. Urology Partners announced a significant growth investment from General Atlantic, a leading global investor. This investment enhances the company’s position as a partner to leading, independent community-based urology practices, enabling them to focus on delivering premier care to the patients they serve. Following the funding from General Atlantic, NMS Capital exited its partnership with the company.
U.S. Urology Partners assists urology practices of all sizes in retaining independence and delivering quality care while practicing medicine in their preferred community-based setting. And the company supports its affiliated groups with deep expertise in business operations, data insights, and technology infrastructure to drive improved patient outcomes and satisfaction and to alleviate the substantial administrative burdens that lead to burnout for many U.S. providers. The company also invests in end-to-end clinical capabilities for genitourinary oncology (primarily prostate, kidney, and bladder cancer, which account for nearly 500,000 new cases annually in the U.S.) and non-oncology treatment pathways.
New board members: Robbert Vorhoff and Jon Michael Reese will join the company’s Board of Directors, which will also include substantial physician representation.
Advisors: Houlihan Lokey served as lead financial advisor to U.S. Urology Partners and NMS Capital. Ernst & Young Capital Advisors also worked as financial advisor to the company and NMS Capital. McDermott Will & Emery provided legal counsel to U.S. Urology Partners and NMS Capital.
KEY QUOTES:
“Since our founding in 2018, U.S. Urology Partners has served as a trusted partner to community-based urology groups across the country. I want to thank the team at NMS Capital for their unwavering stewardship and direction over these years. As we look to our next phase of growth, we are excited to deepen our presence and capabilities across our five existing markets, while expanding into new geographies through affiliating with leading urology practices that share our vision. We are thrilled to enter this next chapter alongside General Atlantic, a partner with an outstanding track record of building and scaling innovative provider organizations across the U.S.”
– Corina Tracy, CEO of U.S. Urology Partners
“We believe U.S. Urology Partners is well-positioned to support a growing desire by community-based urology practices to remain independent as they focus on providing quality patient care and building their businesses. We are excited to partner with Corina and the U.S. Urology Partners team as they continue to expand access to advanced therapies and procedures for their physician partners and the patients they serve.”
– Robbert Vorhoff, Managing Director and Global Head of Healthcare at General Atlantic
“We have been compelled by the opportunity for community-based urology to reach more patients. U.S. Urology Partners is unique as a nationally scaled, fully independent, and clinically renowned urology platform. We are excited to support its next phase of transformative growth.”
– Jon Michael Reese, Principal at General Atlantic
